Dr. Philippe Verplancke member of CDISC E3C

XClinical’s CEO Dr. Philippe Verplancke becomes CDISC E3C member

XClinical’s CEO Dr. Philippe Verplancke becomes CDISC E3C member
XClinical looks back on a successful year 2008
One of XClinical’s customers, the Munich-based CRO OSE Oncology Services Europe S.a.r.l., has just started a large clinical trial for one of Europe’s premier pharmaceutical companies.
XClinical executives will be presenting at two important CDISC European User Group Meetings in January 2008.